Condition: Secondary Malignant Neoplasm of Liver · Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
The surgical and local ablation strategy for the treatment of resectable synchronous and metachronous colorectal liver metastases(CRLM) has not still been defined. The purpose of this study is to compare two treatment strategies in which simultaneous resection of both primary and secondary tumor of synchronous CRLM(SCRLM) and resection of metachronous CRLM(MCRLM) is compared with resection of primary tumor and ablation of secondary tumor in SCRLM and ablation of MCRLM. Endpoints include the rate of severe complications and survival.
This description comes directly from the study's public registry record.
Meijin Huang, MD,PHD · +8613924073322 · maymay0129@139.com
Jun Huang, MD,PHD · +8613926451242 · huangj97@mail.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| The 6th Affiliated Hospital of Sun Yat-Sen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02886104